Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.
about
The intersection of attention-deficit/hyperactivity disorder and substance abuseAdult attention-deficit/hyperactivity disorder and nicotine use: a qualitative study of patient perceptions.Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders.Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?Health state utilities associated with adult attention-deficit/hyperactivity disorder.Ecological momentary assessment of antecedents and consequences of smoking in adults with attention-deficit/hyperactivity disorder.OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences.Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adultsStimulant treatment of ADHD and cigarette smoking: a meta-analysis.Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trial.Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders.Divergence by ADHD subtype in smoking cessation response to OROS-methylphenidate.Methylphenidate increases cigarette smoking in participants with ADHD.Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers.Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the futureSubjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder.Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.Tobacco dependence counseling in a randomized multisite clinical trialA pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHDIncreasing ethnic minority participation in substance abuse clinical trials: lessons learned in the National Institute on Drug Abuse's Clinical Trials Network.Improving the analysis and modeling of substance use.An application of analyzing the trajectories of two disorders: A parallel piecewise growth model of substance use and attention-deficit/hyperactivity disorder.Anxiety and Depressed Mood Decline Following Smoking Abstinence in Adult Smokers with Attention Deficit Hyperactivity Disorder.Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review.Substance-use disorders in adolescents and adults with ADHD: focus on treatment.Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with attention deficit/hyperactivity disorderOsmotic release oral system methylphenidate prevents weight gain during a smoking-cessation attempt in adults with ADHDRisk of methylphenidate-induced prehypertension in normotensive adult smokers with attention deficit hyperactivity disorder.Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHDPreliminary evidence that adherence to counseling mediates the effects of pretreatment self-efficacy and motivation on outcome of a cessation attempt in smokers with ADHDA systematic approach to subgroup analyses in a smoking cessation trial.Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.The National Drug Abuse Treatment Clinical Trials Network: forging a partnership between research knowledge and community practice.Smoking behavior characteristics of non-selected smokers with childhood attention-deficit/hyperactivity disorder (AD/HD) history: a systematic review and meta-analysis.Smoking motivation in adults with attention-deficit/hyperactivity disorder using the Wisconsin inventory of smoking dependence motives.Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response.ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents.
P2860
Q22242685-44DAFFD2-D200-4B8F-95C5-7118E8971E29Q33680015-BB5686B8-E518-4C4F-9740-3291E66AD17FQ33919571-4DA872CB-025E-4DA3-AC35-D20CE573C14CQ33919950-F8C41E77-CC20-45E1-A57B-A0094297E996Q33944593-297A7CA5-7CFD-495F-8286-846C1BD72E60Q33976526-C19DB369-45E4-48EC-9E35-5CE79FF78EDFQ34033147-A37A0BFE-B1A7-4825-B1BA-9AB06D477093Q34092586-4B094C49-025A-4C02-A2AC-196404F8E3FAQ34220004-592E164F-F883-4CB2-B164-7EEC08C87769Q34419671-39F0E47F-B26E-4D30-A122-D07BCF5386EBQ34574051-B27D3AB0-90BB-4266-B314-7B8DA1138D13Q35083923-55B7B114-F6A8-49A9-9927-23462E401EDFQ35231025-0AB08E4F-5096-4950-B648-B07EB600D8E4Q35293009-0F17D16A-6151-4CB5-A1D2-753DA8418D10Q35588731-80A46F5D-D697-438E-860F-F923915F6830Q35598143-4A3228CD-A18E-41C1-924B-B2D024DC1340Q35625911-84C400FC-2DB1-4B7B-9F50-3221A530F6B6Q35661087-2ECBA1DF-7A1F-45C5-9349-EF745551E166Q35991942-8552E308-88C4-444B-A0BE-FE25EBF0D4CDQ36170165-EE6EB739-F5B2-4EF1-94D3-8068830E7CADQ36189611-40535177-2A00-4561-8E68-2F474BC286D6Q36218531-E9AA5910-D94B-43F9-AD3E-0C6026EF1C88Q36315683-DE318DAA-7E2E-4071-A2FC-A5BF14950C80Q36322567-2B015E4C-16A7-4099-9F62-76BFC7396B5CQ36338808-6AAC9152-1310-4ED3-A8E6-FC34A058916CQ36344412-14BB5CFC-6199-4F7E-BDAE-A7716527E494Q36403699-5A0CB9FF-45B5-43BF-8FAE-1B2FCE8BD6CEQ36433737-3CFB30C8-4C1D-4D2E-BC07-5F1011E461A6Q36534998-397BAEFE-608E-48CC-B1D9-5E2BA4E4EBF0Q36567686-B745899E-C937-45B1-951A-BFDEB8192F73Q36708913-8B756B6A-3417-471D-A0F0-FF798737563BQ36727906-A45BEC0B-ABAF-4DD0-8602-F7D748932BB3Q36755553-44557FE4-8B68-4D94-B1CC-1C4A910C67A5Q36759490-E9A14F99-2B78-4ECF-8DE0-9149D7DC05AFQ37355266-2AD5E1E4-2555-43E1-B3D6-3F73F6B44A05Q37405268-1E75DE2B-5958-485A-8F14-886F7E9631C1Q37564225-5CB5FD3C-B939-4502-9F49-B2061AB5F03BQ37625018-2ADB0E49-2747-4545-BB04-E2344167BE3CQ37732338-D79B7537-8751-4ECE-9CA8-3D3C230DAD79Q38023225-0B18E1A7-290A-4F2F-8DAA-CC8D524F3450
P2860
Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Impact of attention-deficit/hy ...... ind, placebo-controlled trial.
@ast
Impact of attention-deficit/hy ...... ind, placebo-controlled trial.
@en
type
label
Impact of attention-deficit/hy ...... ind, placebo-controlled trial.
@ast
Impact of attention-deficit/hy ...... ind, placebo-controlled trial.
@en
prefLabel
Impact of attention-deficit/hy ...... ind, placebo-controlled trial.
@ast
Impact of attention-deficit/hy ...... ind, placebo-controlled trial.
@en
P2093
P2860
P50
P356
P1476
Impact of attention-deficit/hy ...... lind, placebo-controlled trial
@en
P2093
Daniel F Lewis
David S Liu
Emily M Dorer
Eugene C Somoza
Ivana T Croghan
Jeffrey D Leimberger
Lirio S Covey
Roger D Weiss
P2860
P304
P356
10.4088/JCP.09M05089GRY
P577
2010-05-18T00:00:00Z